{
    "title": "Independent Medical Review Act of 1999",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Independent Medical Review Act of \n1999''.\n\nSEC. 2. SPECIAL RULES FOR GROUP HEALTH PLANS.\n\n    Section 503 of the Employee Retirement Income Security Act of 1974 \n(29 U.S.C. 1133) is amended--\n            (1) by inserting ``(a) In General.--'' after ``Sec. 503.'';\n            (2) by inserting ``(other than a group health plan)'' after \n        ``employee benefit plan''; and\n            (3) by adding at the end the following new subsections:\n    ``(b) Special Rules for Group Health Plans.--\n            ``(1) In general.--The claims procedures required by this \n        section shall include--\n                    ``(A) notification to a participant or beneficiary \n                of the participant or beneficiary's right to appeal an \n                adverse determination to a utilization review agent;\n                    ``(B) notification to a participant or beneficiary \n                of the participant or beneficiary's right to appeal an \n                adverse determination of a utilization review agent to \n                an independent review organization;\n                    ``(C) notification to a participant or beneficiary \n                of the procedures for appealing an adverse \n                determination to an independent review organization;\n                    ``(D) notification to a participant or beneficiary \n                who has a life-threatening condition of the participant \n                or beneficiary's right to immediate review by an \n                independent review organization and the procedures to \n                obtain such review; and\n                    ``(E) procedures for a fair, de novo determination \n                of medical necessity by the independent review \n                organization without regard to the definition used by \n                the plan.\n    ``(c) Appeal of Adverse Determination.--In a case in which an \nemployee benefit plan denies a claim for benefits under the plan to a \nparticipant or beneficiary, such participant or beneficiary may appeal \nsuch adverse determination to a utilization review agent. The \nprocedures for appeals shall be reasonable and shall include the \nfollowing:\n            ``(1) A provision indicating that a participant or \n        beneficiary, a person acting on behalf of the participant or \n        beneficiary, or the participant or beneficiary's physician or \n        health care provider may appeal the adverse determination \n        orally or in writing.\n            ``(2) A provision that the utilization review agent shall \n        send to the appealing party, within 5 working days after \n        receipt of a written appeal, a letter acknowledging the date of \n        the utilization review agent's receipt of the appeal and \n        including a reasonable list of documents needed to be submitted \n        by the appealing party to the utilization review agent for the \n        appeal.\n            ``(3) In a case in which a utilization review agent \n        receives an oral appeal of adverse determination, the \n        utilization review agent shall send a one page appeal form to \n        the appealing party.\n            ``(4) A provision that appeal decisions shall be made by a \n        physician, provided that, if the appeal is denied and within 10 \n        working days the health care provider sets forth in writing \n        good cause for having a particular type of a specialty provider \n        review the case, the denial shall be reviewed by a health care \n        provider in the same or similar specialty as typically manages \n        the medical, dental, or specialty condition, procedure, or \n        treatment under discussion for review of the adverse \n        determination, and such specialty review shall be completed \n        within 15 working days of receipt of the request.\n            ``(5) A method for an expedited appeal procedure for \n        emergency care denials, denials of care for life threatening \n        conditions, and denials of continued stays for hospitalized \n        patients. Such procedure shall include a review by a health \n        care provider who has not previously reviewed the case who is \n        of the same or a similar specialty as typically manages the \n        medical condition, procedure, or treatment under review. The \n        time frame in which such appeal must be completed shall be \n        based on the medical or dental immediacy of the condition, \n        procedure, or treatment, but may in no event exceed one working \n        day from the date all information necessary to complete the \n        appeal is received.\n            ``(6) A provision that after the utilization review agent \n        has sought review of the appeal of the adverse determination, \n        the utilization review agent shall issue a response letter to \n        the patient, person acting on behalf of the patient, or the \n        patient's physician or health care provider explaining the \n        resolution of the appeal. Such letter shall include a statement \n        of the specific medical, dental, or contractual reasons for the \n        resolution, the clinical basis for such decision, and the \n        specialization of any physician or other provider consulted.\n            ``(7) Written notification to the appealing party of the \n        determination of the appeal, as soon as practical, but in no \n        case later than 30 days after the date of the utilization \n        review agent receives the appeal.\n    ``(d) Independent Review of Adverse Determinations.--\n            ``(1) In general.--In a case in which an appeal of an \n        adverse determination is denied by a utilization review agent, \n        a participant or beneficiary may seek review of such adverse \n        determination from an independent review organization.\n            ``(2) Elements of independent review process.--\n                    ``(A) In general.--The independent review process \n                under this subsection shall be conducted by an \n                independent review organization and shall ensure--\n                            ``(i) a timely response by the independent \n                        review organization;\n                            ``(ii) confidentiality of medical records \n                        transmitted for use in the review process;\n                            ``(iii) the independence of each health \n                        care provider or physician making review \n                        determinations as part of an independent review \n                        organization; and\n                            ``(iv) timely notice to the participant or \n                        beneficiary of the results of the independent \n                        review, including the clinical basis for the \n                        determination.\n                    ``(B) Information provided to the independent \n                review organization.--Not later than 3 business days \n                after the date that an independent review organization \n                receives a request for a review of an adverse \n                determination of a utilization review agent, such \n                utilization review agent shall provide to the \n                appropriate independent review organization--\n                            ``(i) any medical records of the \n                        participant or beneficiary that are relevant to \n                        the review;\n                            ``(ii) any documents used by the \n                        utilization review agent in making the \n                        determination that is to be reviewed by the \n                        organization;\n                            ``(iii) written notification to the \n                        participant or beneficiary indicating the \n                        clinical basis for the denial of the appeal;\n                            ``(iv) any documentation and written \n                        information submitted to the utilization review \n                        agent in support of the appeal; and\n                            ``(v) a list of each physician or health \n                        care provider who has provided care to the \n                        participant or beneficiary and who may have \n                        medical records relevant to the appeal.\n                    ``(C) Timelines for determinations by independent \n                review organization.--\n                            ``(i) In general.--An independent review \n                        organization shall make its determination not \n                        later than the earlier of--\n                                    ``(I) the 15th day after the date \n                                the independent review organization \n                                receives the information necessary to \n                                make the determination; or\n                                    ``(II) the 20th day after the date \n                                the independent review organization \n                                receives the request that the \n                                determination be made.\n                            ``(ii) Life-threatening condition.--In the \n                        case of a life-threatening condition, an \n                        independent review organization shall make its \n                        determination not later than the earlier of--\n                                    ``(I) the 5th day after the date \n                                the independent review organization \n                                receives the information necessary to \n                                make the determination; or\n                                    ``(II) the 8th day after the date \n                                the independent review organization \n                                receives the request that the \n                                determination be made.\n            ``(3) Certification of independent review organizations.--\n                    ``(A) In general.--To be treated as an independent \n                review organization, an organization must be certified \n                by the Secretary.\n                    ``(B) Application for certification.--To be \n                certified by the Secretary as an independent review \n                organization, an organization shall submit on an annual \n                basis to the Secretary an application which shall \n                include the following information:\n                            ``(i) Any applicant that is a publicly held \n                        organization shall include the name of each \n                        stockholder or owner of more than 5 percent of \n                        any stock or options.\n                            ``(ii) The name and type of business of \n                        each corporation or other organization that the \n                        applicant controls or is affiliated with and \n                        the nature and extent of the affiliation or \n                        control.\n                            ``(iii) The name of any holder of bonds or \n                        notes of the applicant that exceed $100,000.\n                            ``(iv) The name and a biographical sketch \n                        of each director, officer, and executive of the \n                        applicant.\n                            ``(v) A description of any relationship the \n                        individuals in clauses (iii) and (iv) have \n                        with--\n                                    ``(I) a provider of health \n                                insurance coverage;\n                                    ``(II) a health maintenance \n                                organization;\n                                    ``(III) a utilization review agent;\n                                    ``(IV) a nonprofit health \n                                corporation;\n                                    ``(V) a payor;\n                                    ``(VI) a health care provider; or\n                                    ``(VII) a group representing any of \n                                the entities described in subclauses \n                                (I) through (VII).\n                            ``(vi) The percentage of the applicant's \n                        revenues that are anticipated to be derived \n                        from reviews conducted under this subsection.\n                            ``(vii) A description of the areas of \n                        expertise of the health care professionals \n                        making review determinations for the applicant.\n                            ``(viii) The procedures to be used by the \n                        independent review organization in making \n                        review determinations with respect to reviews \n                        conducted under this section.\n            ``(4) Independent review determination binding on plan.--\n                    ``(A) In general.--Subject to subparagraph (B), the \n                determination by an independent review organization \n                under this subsection shall be treated as the final \n                decision of the plan.\n                    ``(B) Vacation or modification of decision.--The \n                determination by an independent review entity under \n                this section may be vacated or modified by a court \n                under the same circumstances as the decision of an \n                arbitrator may be vacated or modified under sections 10 \n                and 11 of title 9, United States Code.\n            ``(5) Independence requirement.--An independent review \n        organization may not be a subsidiary of, or in any way owned or \n        controlled by a payor or a trade or professional association of \n        a payor.\n            ``(6) Waiver of liability.--An independent review \n        organization conducting a review under this section is not \n        liable for damages arising from the determination made by the \n        organization.\n    ``(e) Definitions.--For purposes of this section:\n            ``(1) Adverse determination.--The term `adverse \n        determination' means determination by a group health plan or a \n        utilization review agent that the health care services \n        furnished or proposed to be furnished to a participant or \n        beneficiary are not medically necessary.\n            ``(2) Health care provider.--The term `health care \n        provider' means--\n                    ``(A) any individual who is engaged in the delivery \n                of health care services in a State and who is required \n                by State law or regulation to be licensed or certified \n                by the State to engage in the delivery of such services \n                in the State; and\n                    ``(B) any entity that is engaged in the delivery of \n                health care services in a State and that, if it is \n                required by State law or regulation to be licensed or \n                certified by the State to engage in the delivery of \n                such services in the State, is so licensed.\n            ``(3) Life-threatening condition.--The term `life-\n        threatening condition' means a disease or other medical \n        condition with respect to which death or serious bodily injury \n        is probable unless the course of the disease or condition is \n        interrupted.\n            ``(4) Payor.--The term `payor' means--\n                    ``(A) an insurer writing health insurance policies;\n                    ``(B) any preferred provider organization, or \n                health maintenance organization, self-insurance plan; \n                or\n                    ``(C) any person or entity that provides, offers to \n                provide, or administers hospital, outpatient, medical, \n                or other health benefits to an individual treated by a \n                health care provider.\n            ``(5) Utilization review agent.--The term `utilization \n        review agent' means an entity that conducts utilization review \n        for--\n                    ``(A) an employer with employees who are covered \n                under a group health plan;\n                    ``(B) a payor; or\n                    ``(C) an administrator.\n            ``(6) Working day.--The term `working day' means a weekday, \n        excluding any legal holiday.''."
}